Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ·Healthcare·Biotechnology

$5.90

-0.50%

Mkt Cap $4.29M

No analyst coverage available

We don't have analyst ratings or price target data for Aspire Biopharma Holdings, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.